Mechanisms involved in the regulation of histone lysine demethylases

Lan, Fei; Nottke, Amanda C.; Shi, Yang

doi:10.1016/j.ceb.2008.03.004

Cited by 223 publications

(198 citation statements)

References 66 publications

Supporting

Mentioning

193

Contrasting

Unclassified

Order By: Relevance

“…The relevance of other lysine demethylases to tumor formation and/or metastasis awaits further studies. Readers are referred to references 3,49 for details of the enzymology and molecular mechanisms of histone lysine demethylases.…”

Section: Discussionmentioning

confidence: 99%

Epigenetic regulation of cancer growth by histone demethylases

Lim

Metzger

Schüle

et al. 2010

Intl Journal of Cancer

View full text Add to dashboard Cite

Cancer is traditionally viewed as a primarily genetic disorder. However, it is now increasingly apparent that epigenetic abnormalities play a fundamental role in cancer development. Aberrant expression of histone-modifying enzymes has been implicated in the course of tumor initiation and progression. The discovery of a large number of histone demethylases suggests an important role for dynamic regulation of histone methylation in biological processes. The observation that overexpression, amplification or mutations of several histone demethylases have been found in many types of tumors, raise the possibility of using these enzymes as diagnostic tools as well as pave a way for the discovery of novel therapeutic targets and treatment modalities. Here, we review the current knowledge of the potential role of H3K4, H3K9 and H3K27 histone demethylases in tumorigenesis.Recently, it has become apparent that not only genetic mutations but also epigenetic alterations lead to the activation of oncogenes and the loss of function of tumor-suppressor genes. Since epigenetic abnormalities in DNA methylation patterns as well as histone modifications are potentially reversible in contrast to gene mutations, much effort has been directed toward understanding the mechanism of epigenetic aberration to develop epigenetic therapies. Indeed, inhibitors of histone deacetylases (HDACs) and DNA methyltransferases (DNMTs) have been approved for treatment of certain types of cancers. Recently, overexpression, amplification or mutations of several histone demethylases have been linked to many types of tumor, raising the possibility of using these enzymes as diagnostic tools and therapeutic targets. Here, we focus mainly on the potential role of some selected histone lysine demethylases in tumorigenesis.The N-terminal tails of histones are subjected to several types of post-translational modifications, including acetylation, methylation, phosphorylation and ubiquitination. The combination of these modifications determines chromatin structure and transcriptional activation or repression of genes. In contrast to other histone modifications, the importance of histone methylations is highlighted because of their enormously specific dynamics with respect to gene regulation. Histone lysine residues on histone H3 and H4 (H3K4, H3K9, H3K27, H3K36, H3K79 and H4K20) can become mono-, dior trimethylated. These modifications are regulated by two classes of enzymes with opposing activities: histone methyltransferases and histone lysine demethylases. LSD1, also known as AOF2 and KDM1, is the first discovered histone lysine demethylase that belongs to the flavin adenine dinucleotide-dependent enzyme family. 1 Subsequently, another family of histone lysine demethylases structurally different from LSD1 was described, all of which sharing the conserved jumonji C (JmjC) domain (Table 1). H3K4 Demethylases in Cancer LSD1/KDM1ATri-and dimethylated H3K4 (H3K4me3/2) are often found at actively transcribed genes. Although H3K4me3 is highly enriched around transcrip...

show abstract

Section: Discussionmentioning

confidence: 99%

Epigenetic regulation of cancer growth by histone demethylases

Lim

Metzger

Schüle

et al. 2010

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

“…Both the binding and recruitment of LSD1 are stimulated by cAMP-PKA or serum. LSD1 is a flavin adenine dinucleotide (FAD)-containing enzyme, which generates H 2 O 2 during the demethylation process (Forneris et al, 2005;Anand and Marmorstein, 2007;Lan et al, 2008). Oxidation of guanine by H 2 O 2 recruits components of the base excision repair system, the 8-oxoguanine-DNA glycosylase, OGG1, and the Ape1 lyase (Sidorenko et al, 2007;Tell et al, 2008) on the E-box and promoter chromatin regions of Myc-target genes.…”

Section: Introductionmentioning

confidence: 99%

LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription

et al. 2010

View full text Add to dashboard Cite

Myc is a transcription factor that significantly contributes to cancer progression by modulating the expression of important genes through binding to a DNA sequence, CACGTG, called E-box. We find that on Myc binding to chromatin, the lysine-demethylating enzyme, LSD1, triggers a transient demethylation of lysine 4 in the histone H3. In addition, we demonstrate that Myc binds and recruits LSD1 to the E-box chromatin and the formation of this complex is stimulated by cAMP-PKA. Demethylation by LSD1 produces H 2 O 2 , which locally oxidizes guanine and induces the recruitment of 8-oxoguanine-DNA glycosylase (OGG1) and of the nuclease Ape1 on the E-box chromatin. Inhibition of oxidation or silencing of LSD1, OGG1 or Ape1 significantly reduce transcription and inhibit mRNA accumulation of Myc-target genes. Collectively, these data highlight the role of transient LSD1-mediated demethylation of H3K4 leading to local DNA oxidation as driving force in the assembly of the Myc-induced transcription initiation complex.

show abstract

“…A 'writer-reader-eraser' post-translational modification regulatory system consisting of a large number of methyltransferases 8,9 , methyl-recognition domain-containing proteins 10 and putative demethylases 11 are expressed in different subcellular locations in humans, an indication that protein methylation is involved in processes other than epigenetic regulation.…”

mentioning

confidence: 99%

A Y2H-seq approach defines the human protein methyltransferase interactome

et al. 2013

View full text Add to dashboard Cite

A 'writer-reader-eraser' post-translational modification regulatory system consisting of a large number of methyltransferases 8,9 , methyl-recognition domain-containing proteins 10 and putative demethylases 11 are expressed in different subcellular locations in humans, an indication that protein methylation is involved in processes other than epigenetic regulation.We prepared 82 Y2H bait strains spanning human R-methyltransferases (PRMT1-PRMT8) 8 , 16 SET domaincontaining K-methyltransferases (PKMTs) 9 , 9 members of the JMJD domain-containing protein family of protein demethylases and AOF2 (LSD1) 11 (Supplementary Table 1). In our current matrix screening protocol 4,12 , we perform four replicates, testing every set of baits individually against each of the ~13,000 prey contained in the matrix. Interacting prey are identified by their position in the matrix. To increase the sensitivity of the approach while also reducing the workload, we used a pooled strategy to test each protein pair substantially more than four times. Baits were pooled with all prey strains and then assayed for interaction in more than 100,000 separate spots ( Fig. 1a and Supplementary Fig. 1). Using Y2H-seq, we obtained 4-10 times the number of positive colonies obtained with the matrix approach. To reveal the prey identities, we collected all colonies and performed a 36-base parallel sequencing run. More than 20 million reads mapped perfectly to human RefSeq coding sequences (open reading frames, ORFs), corresponding to more than 500,000 unique 36-base reads (Supplementary Table 2). To rank the potentially interacting proteins for subsequent interaction retesting, we calculated a 'SeqScore' that incorporates the number of total mappings and the number of unique reads matching the ORF ( Supplementary Fig. 2). Notably, >99.7% of the RefSeq mappings matched to the 400 top-ranked genes, thus allowing the identification of potentially interacting ORFs with an extremely high signal-tobackground ratio (Supplementary Table 2).We performed four biological replicates and demonstrated in statistical pairwise comparisons that they result in very similar ranked prey orders (Supplementary Fig. 3). Top-ranked prey in at least two replicate screens were retested against all baits in a pairwise manner (Supplementary Fig. 4) and yielded 463 protein interactions (Supplementary Table 3). The success rate of the retest-that is, the probability that the prey is interactingdecreased with decreasing SeqScore (Fig. 1b).We also performed a matrix screen in quadruplicate with a subset of the protein methyltransferase (PMT) and protein demethylase (PDeM) baits for direct method comparison. With the matrix approach, we found 151 interactions (Supplementary to accelerate high-density interactome mapping, we developed a yeast two-hybrid interaction screening approach involving short-read second-generation sequencing (Y2h-seq) with improved sensitivity and a quantitative scoring readout allowing rapid interaction validation. We applied Y2h-seq to investigate enzymes in...

show abstract

Mechanisms involved in the regulation of histone lysine demethylases

Cited by 223 publications

References 66 publications

Epigenetic regulation of cancer growth by histone demethylases

Epigenetic regulation of cancer growth by histone demethylases

LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription

A Y2H-seq approach defines the human protein methyltransferase interactome

Contact Info

Product

Resources

About